|
|
Post by dreamboatcruise on Sept 13, 2017 18:54:04 GMT -5
Despite the recent share price rise, which I have to admit I don't fully understand, there is still that nagging issue, that big huge elephant in the room about financing. Mike seemed confident but certainly lacking in specifics at the recent conference. He is setting himself up for a huge win/lose situation. If he can make a nondilutive deal that carries the company for a decent amount of time then he wins. If not, the share price will tank in my opinion. He would have to produce some serious sales to earn his way out of the situation. Unless there is some big deal in the works I remain concerned about the future of Mannkind. We are off the rock bottom because it had become clear that 1: Mike had find ways to cash flow positive. 2: Investors had shown up or hadn't been scared away so Mike will get enough cash to get us to cash flow positive. We are not higher because we do not know if dilution can be avoided or how bad it would be if it couldn't. Our building or other ways must be close, but might be not quite enough. My take is that let's dillute but have the money to be sure. If it turned out that we over capitalized, return the money buying some shares back. I am sure, even with dillution, as long as Affreza become successful, we will be many bagger from here. 10 bagger vs. 20 bagger, or X baager is the difference I see, and is not really different very much really. If investors thought there was path to positive cash flow that didn't involve massive dilution the share price would be MUCH higher than where it is today. Even after coming of the rock bottom, the stock is still pricing in significant risk of bk or massive dilution. I would agree with the first four words of your sentence I've bolded above... in the big picture "We are not higher" (full stop to the sentence)... we are in fact still at a market cap decimated from where it was when success was factored in. We are in fact WAY down low "because we do not know if dilution can be avoided or how bad it would be if it couldn't." There may be some subset of investors that believe the risks are off the table, but it ain't a large percentage or we wouldn't be trading at the pre split equivalent of $0.45. I'm beginning to be hopeful Mike will pull a rabbit out of the hat and avoid large dilution, but I certainly don't believe that is the prevailing view. BTW... if company is successful, it actually would make a significant difference to some whether it is 10 bagger from here vs 20 or 50. 10 would leave many including those that got in at IPO having lost over half of their investment. It would probably take 25 to make them whole and 30-35 to make the investment worthwhile compared to an S&P index ETF. (numbers are guestimates only). That's a good indication of how not-high the share price is. |
|
|
|
Post by straightly on Sept 13, 2017 21:36:22 GMT -5
We are off the rock bottom because it had become clear that 1: Mike had find ways to cash flow positive. 2: Investors had shown up or hadn't been scared away so Mike will get enough cash to get us to cash flow positive. We are not higher because we do not know if dilution can be avoided or how bad it would be if it couldn't. Our building or other ways must be close, but might be not quite enough. My take is that let's dillute but have the money to be sure. If it turned out that we over capitalized, return the money buying some shares back. I am sure, even with dillution, as long as Affreza become successful, we will be many bagger from here. 10 bagger vs. 20 bagger, or X baager is the difference I see, and is not really different very much really. If investors thought there was path to positive cash flow that didn't involve massive dilution the share price would be MUCH higher than where it is today. Even after coming of the rock bottom, the stock is still pricing in significant risk of bk or massive dilution. I would agree with the first four words of your sentence I've bolded above... in the big picture "We are not higher" (full stop to the sentence)... we are in fact still at a market cap decimated from where it was when success was factored in. We are in fact WAY down low "because we do not know if dilution can be avoided or how bad it would be if it couldn't." There may be some subset of investors that believe the risks are off the table, but it ain't a large percentage or we wouldn't be trading at the pre split equivalent of $0.45. I'm beginning to be hopeful Mike will pull a rabbit out of the hat and avoid large dilution, but I certainly don't believe that is the prevailing view. BTW... if company is successful, it actually would make a significant difference to some whether it is 10 bagger from here vs 20 or 50. 10 would leave many including those that got in at IPO having lost over half of their investment. It would probably take 25 to make them whole and 30-35 to make the investment worthwhile compared to an S&P index ETF. (numbers are guestimates only). That's a good indication of how not-high the share price is. I do not think the risk is off the table at all. Even if I am right, I believe all we have is enough cash to give Mike's marketing/commercializing plan one honest try and that cash will come ONLY with hurting dilution. Anything better will mean my recent purchases were serious bargains. |
|
|
|
Post by mango on Sept 13, 2017 22:18:15 GMT -5
Ya'll gotta realize that Technosphere is an FDA approved new chemical entity that belongs to MannKind Corporation. It is a carrier particle that mimics the pharmacokinetics of intra-arterial administration and it is not a penetration enhancer—it does not disrupt the integrity of a cell. Nothing else exists like this. It is the safest pulmonary delivery system in the world. Afrezza literally corrects the imbalance and restores glucose homeostasis for people with diabetes. This was not achievable before Afrezza. Please realize this is so much more awesome than what you might think. This is literally what restoring health looks like  |
|
|
|
Post by cretin11 on Sept 13, 2017 22:21:07 GMT -5
mango what you say about TS may be true, but that's been the situation for years now but yet no partnership deals bringing much needed cash. is now the time to turn that potential into $$$? and why not before now?
|
|
|
|
Post by mango on Sept 13, 2017 22:24:45 GMT -5
mango what you say about TS may be true, but that's been the situation for years now but yet no partnership deals bringing much needed cash. is now the time to turn that potential into $$$? and why not before now? What I said about Technosphere is not maybe true, it is true. |
|
|
|
Post by mango on Sept 13, 2017 22:25:56 GMT -5
mango what you say about TS may be true, but that's been the situation for years now but yet no partnership deals bringing much needed cash. is now the time to turn that potential into $$$? and why not before now? Finding a non-corrupt company takes time. Patience |
|
|
|
Post by falconquest on Sept 14, 2017 4:27:35 GMT -5
Ya'll gotta realize that Technosphere is an FDA approved new chemical entity that belongs to MannKind Corporation. It is a carrier particle that mimics the pharmacokinetics of intra-arterial administration and it is not a penetration enhancer—it does not disrupt the integrity of a cell. Nothing else exists like this. It is the safest pulmonary delivery system in the world. Afrezza literally corrects the imbalance and restores glucose homeostasis for people with diabetes. This was not achievable before Afrezza. Please realize this is so much more awesome than what you might think. This is literally what restoring health looks like We know this is true mango, no one disputes the efficacy of Afrezza/Technosphere. However, do you recall the "call me" reference Hakan made in regard to Technosphere partnerships? You know, the one that resulted in him being outed as CEO? My guess is his phone wasn't exactly ringing off the hook. To date there have been few takers of any consequence for Technosphere. The other fact is that adoption of Afrezza has been extremely slow. These facts have resulted in a cash drain at Mannkind with few options left. It's possible that Mike could pull this off but wow, what a risky situation we are in. If you can't recognize that then I submit that you're not being honest with yourself. |
|
|
|
Post by dreamboatcruise on Sept 14, 2017 5:43:58 GMT -5
mango what you say about TS may be true, but that's been the situation for years now but yet no partnership deals bringing much needed cash. is now the time to turn that potential into $$$? and why not before now? What I said about Technosphere is not maybe true, it is true. Yes, and betamax rules... in lore. |
|
|
|
Post by sportsrancho on Sept 14, 2017 6:45:01 GMT -5
Mango is very very smart new money:-) There will be more coming on board. IMO.
The new generation of MNKD investors. They will all be excited and fresh faced. That's what we need.
I'm envious.
But someday knowing that kids will have the best insulin possible makes it easier for me to keep fighting, and start over once again. Long hard road, but it seems we are on the right side of the road this time! Although with a short time to get there:-)
|
|
|
|
Post by boca1girl on Sept 14, 2017 7:18:30 GMT -5
I agree with most of the comments on this thread.
YES to best technology and best outcomes for patients but also... YES to lack of partners and cash to keep the dream of wild success alive much longer.
I won't love it, but would welcome dilution to keep the lights on and keep the dream alive for as long as possible.
|
|
|
|
Post by promann on Sept 14, 2017 8:10:08 GMT -5
Mango is very very smart new money:-) There will be more coming on board. IMO. The new generation of MNKD investors. They will all be excited and fresh faced. That's what we need. I'm envious. But someday knowing that kids will have the best insulin possible makes it easier for me to keep fighting, and start over once again. Long hard road, but it seems we are on the right side of the road this time! Although with a short time to get there:-) I'm also envious of the new investers getting in on the bottom floor when we have been here for years and endured much pain. But what I think will happen with these new investers is they will sell at the 2nd floor, where us old timers are going to see this through to the 100th floor and the newbies will be kicking themselves in the buttocks.😉 |
|
|
|
Post by n8 on Sept 14, 2017 9:12:47 GMT -5
Mango is very very smart new money:-) There will be more coming on board. IMO. The new generation of MNKD investors. They will all be excited and fresh faced. That's what we need. I'm envious. But someday knowing that kids will have the best insulin possible makes it easier for me to keep fighting, and start over once again. Long hard road, but it seems we are on the right side of the road this time! Although with a short time to get there:-) I'm also envious of the new investers getting in on the bottom floor when we have been here for years and endured much pain. But what I think will happen with these new investers is they will sell at the 2nd floor, where us old timers are going to see this through to the 100th floor and the newbies will be kicking themselves in the buttocks.😉 Not me. I believe in Mannkind for the potential financial gain yes, but even more so for the diversity of the tech and how afrezza can help so many people. I dont like the fact that afrezza works so well that it may end up enabling people to continue to ignore the fact that most of their poor health can be attributed to the western diet and lack of exercise. Im in for the long haul and looking forward to the dividends. |
|
|
|
Post by boca1girl on Sept 14, 2017 11:23:18 GMT -5
This thread is way off topic.
Fidelity increased the interest they pay for loaned shares to 49% this morning.
|
|
|
|
Loan Rate
Sept 14, 2017 12:38:38 GMT -5
via mobile
Post by saxcmann on Sept 14, 2017 12:38:38 GMT -5
This thread is way off topic. Fidelity increased the interest they pay for loaned shares to 49% this morning. I'm guessing we'll go above 50% next few days. if scripts are good Friday they'll need to hold us down. if label is good then we might see 60% until dilution news hits? |
|
|
|
Loan Rate
Sept 14, 2017 13:20:38 GMT -5
via mobile
Post by ghochr on Sept 14, 2017 13:20:38 GMT -5
This thread is way off topic. Fidelity increased the interest they pay for loaned shares to 49% this morning. I'm guessing we'll go above 50% next few days. if scripts are good Friday they'll need to hold us down. if label is good then we might see 60% until dilution news hits? Looking at your post history.. do you have a doc friend? If you do how is he doing on Afrezza RX? |
|
